Pyroglutamic acid-induced metabolic acidosis: a case report

Acta Clin Belg. 2014 Jun;69(3):221-3. doi: 10.1179/2295333714Y.0000000022. Epub 2014 Apr 2.

Abstract

High anion gap metabolic acidosis due to pyroglutamic acid (5-oxoproline) is a rare complication of acetaminophen treatment (which depletes glutathione stores) and is often associated with clinically moderate to severe encephalopathy. Acquired 5-oxoprolinase deficiency (penicillins) or the presence of other risk factors of glutathione depletion such as malnutrition or sepsis seems to be necessary for symptoms development. We report the case of a 55-year-old women who developed a symptomatic overproduction of 5-oxoproline during flucloxacillin treatment for severe sepsis while receiving acetaminophen for fever control. Hemodialysis accelerated the clearance of the accumulated organic acid, and was followed by a sustained clinical improvement.

Keywords: Acetaminophen/adverse effects,; Acidosis/chemically induced,; Pyrrolidonecarboxylic acid/metabolism,; Renal dialysis; Sepsis/complications,.

Publication types

  • Case Reports

MeSH terms

  • Acetaminophen / adverse effects
  • Acidosis / chemically induced*
  • Acidosis / diagnosis
  • Acidosis / therapy
  • Anti-Bacterial Agents / adverse effects
  • Antipyretics / adverse effects
  • Female
  • Fever / drug therapy
  • Fever / etiology
  • Floxacillin / adverse effects
  • Humans
  • Middle Aged
  • Pyrrolidonecarboxylic Acid / adverse effects*

Substances

  • Anti-Bacterial Agents
  • Antipyretics
  • Acetaminophen
  • Floxacillin
  • Pyrrolidonecarboxylic Acid